Angiotech Pharmaceuticals (Vancouver, British Columbia) reported that it has completed its acquisition of Edwards Lifesciences (Irvine, California) Lifespan ePTFE vascular graft business, located in Laguna Hills, California, for $14 million in cash. The deal was first disclosed in November 2005.